Purdue Innovates

.@AmpSciences, a diagnostics life sciences company revolutionizing early disease detection, announced Friday, May 8 the launch of PanAMP, a clinical utility study for its PanCystPro assay. Read more: bit.ly/4u4pmyA

Congratulation to Novin AgriTech, a startup that licenses @LifeAtPurdue IP from the Office of Technology Commercialization. It has received an $175K SBIR grant from the @USDA: bit.ly/4uAQmps

Purdue Innovates Incubator awarded $50,000 to four teams of @LifeAtPurdue student entrepreneurs during the annual New Venture Challenge last week! Read more: bit.ly/4eiqWba

🚀 AI is everywhere. Production-ready AI is where things get real. Six Feet Up CTO @calvinhp joins @lolavisionsys CEO Tayo Adesanya on the @PurdueInnovates panel, “Commercializing AI.” 🤖 👉Infrastructure, data readiness & hardware/software convergence sixfeetup.com/company/events…

.@LifeAtPurdue is becoming "The Semiconductor University," and several Purdue Engineering professors are at the helm. On the three-year anniversary of the Purdue Computes initiative, read more about the campus-wide push involving @PurdueECE, @PurdueME and other units: bit.ly/4mp5Euj

Congratulations to @helpwithleto, an Indiana startup and public benefit corporation, for launching its software system that allows users to more efficiently connect their clients with community resources. Read more: bit.ly/4dwSARq

When you use an AI photo editor, you're uploading your face to a cloud platform and losing control of your biometric data. More about a patent-pending fix by @purdue_ie and @PurdueECE researchers, published in @IEEEorg Transactions on Artificial Intelligence: bit.ly/47rkSsw @PurdueInnovates

Can you dig it? @PurdueCCE and @PurdueInnovates radar technology could decrease hazardous strikes to underground utility pipes during construction projects. How the patent-pending tech could lower related financial losses, service disruptions, injuries and fatalities: bit.ly/4rNQCQK

The Purdue Quantum Code Library can inexpensively and quickly model semiconductors that are ultrasmall yet high performing and resilient. How electronics manufacturers could benefit: bit.ly/3OUhf83 @PurdueECE | @PurdueInnovates

A patent-pending tool from @LifeAtPurdue to stop AI from exposing private identities during photo editing and sharing is available for licensing and commercializing. Read more: bit.ly/4rsEBPJ @PurdueEngineers @PurdueScience | @PurdueCS

Congratulations to Wavelogix, which licenses @LifeAtPurdue concrete sensor innovations through the Purdue Innovates Office of Technology Commercialization. The company has received a $500,000 SBIR Phase IIB grant from @NSF: bit.ly/47ekiOX @PurdueEngineers | @PurdueCCE

A patent-pending @LifeAtPurdue 3D object detection system dynamically adjusts detection strategies based on real-time hardware constraints. AGILE3D is available for licensing and commercialization: bit.ly/4s4LXKg @PurdueEngineers | @PurdueAg | @PurdueABE

Purdue University mourns the loss of Phil Low, drug discovery scholar and decorated innovator, who died Wednesday (March 4) at the age of 78. purdue.university/4aTRYUd

.@LifeAtPurdue tech to decrease hazardous strikes to underground utility pipes during construction projects is available for licensing and development. Read more: bit.ly/3NlwCpD @PurdueEngineers | @PurdueCCE #Purdue #Construction #Pipes

A new @LifeAtPurdue vaccine that could address wild animal overpopulation is available for development and commercialization. Read more: bit.ly/4u3B2SA #Wildlife #Overpopulation #Vaccine

Electronics manufacturers can get nonexclusive licenses for @LifeAtPurdue’s Quantum Code Library, which models semiconductors as small as 2-3 nm. Read more: bit.ly/4aZiVV9 #Code #Modeling #Semiconductors

.@AmpSciences, which licenses @purduepharmacy innovations, has reached a new milestone for the commercial scaling of its lead assay for pancreatic cancer risk stratification. Read more: bit.ly/46UTxin

A drug first developed at Purdue is moving forward in the fight against glioblastoma. Gibson Oncology + NIH have launched a Phase 2 trial of LMP744 for first-time recurrent glioblastoma. Originally designed at Purdue by a research group led by PICR member emeritus Mark Cushman, the drug targets topo 1 + cMYC. ~40 patients will be enrolled. purdue.link/glioblastoma-t…

Phase 2 clinical trials are begun on a glioblastoma treatment designed and synthesized at @LifeAtPurdue and commercialized by @GibsonOncology. Read more: bit.ly/4b7XgLM #Cancer #Glioblastoma #ClinicalTrials

Congratulations, Sunandita Ghosh! @PurdueInnovates named the @PurdueFoodSci post doc research assistant a 2026 Commercialization Fellow, awarded to early‑career researchers turning breakthrough ideas into real‑world solutions. stories.prf.org/purdue-commerc…